Advertisement
AMED vs CYH
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMED is a Buy and CYH is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AMED’s FA Score shows that 0 FA rating(s) are green whileCYH’s FA Score has 1 green FA rating(s).
- AMED’s FA Score: 0 green, 5 red.
- CYH’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AMED’s TA Score shows that 4 TA indicator(s) are bullish while CYH’s TA Score has 4 bullish TA indicator(s).
- AMED’s TA Score: 4 bullish, 4 bearish.
- CYH’s TA Score: 4 bullish, 4 bearish.
Price Growth
AMED (@Medical/Nursing Services) experienced а +2.49% price change this week, while CYH (@Medical/Nursing Services) price change was -17.51% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.81%. For the same industry, the average monthly price growth was +2.11%, and the average quarterly price growth was +9.68%.
Reported Earning Dates
AMED is expected to report earnings on Jul 23, 2025.
CYH is expected to report earnings on Jul 23, 2025.
Industries' Descriptions
@Medical/Nursing Services (+1.81% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| AMED | CYH | AMED / CYH | |
| Capitalization | 3.02B | 459M | 658% |
| EBITDA | 129M | 1.54B | 8% |
| Gain YTD | 6.664 | 8.696 | 77% |
| P/E Ratio | 1170.50 | 2.21 | 53,020% |
| Revenue | 2.24B | 12.5B | 18% |
| Total Cash | 126M | 38M | 332% |
| Total Debt | 487M | 12.2B | 4% |
AMED | CYH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 5 | 78 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 73 Overvalued | 27 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 95 | |
SMR RATING 1..100 | 77 | 100 | |
PRICE GROWTH RATING 1..100 | 56 | 39 | |
P/E GROWTH RATING 1..100 | 51 | 100 | |
SEASONALITY SCORE 1..100 | 3 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CYH's Valuation (27) in the Hospital Or Nursing Management industry is somewhat better than the same rating for AMED (73) in the Medical Or Nursing Services industry. This means that CYH’s stock grew somewhat faster than AMED’s over the last 12 months.
CYH's Profit vs Risk Rating (95) in the Hospital Or Nursing Management industry is in the same range as AMED (100) in the Medical Or Nursing Services industry. This means that CYH’s stock grew similarly to AMED’s over the last 12 months.
AMED's SMR Rating (77) in the Medical Or Nursing Services industry is in the same range as CYH (100) in the Hospital Or Nursing Management industry. This means that AMED’s stock grew similarly to CYH’s over the last 12 months.
CYH's Price Growth Rating (39) in the Hospital Or Nursing Management industry is in the same range as AMED (56) in the Medical Or Nursing Services industry. This means that CYH’s stock grew similarly to AMED’s over the last 12 months.
AMED's P/E Growth Rating (51) in the Medical Or Nursing Services industry is somewhat better than the same rating for CYH (100) in the Hospital Or Nursing Management industry. This means that AMED’s stock grew somewhat faster than CYH’s over the last 12 months.
| AMED | CYH | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 44% | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 53% | 2 days ago 81% |
| Momentum ODDS (%) | 2 days ago 47% | 2 days ago 89% |
| MACD ODDS (%) | 2 days ago 53% | 2 days ago 78% |
| TrendWeek ODDS (%) | 2 days ago 48% | 2 days ago 85% |
| TrendMonth ODDS (%) | 2 days ago 40% | 2 days ago 84% |
| Advances ODDS (%) | 2 days ago 51% | 15 days ago 83% |
| Declines ODDS (%) | 21 days ago 59% | 2 days ago 86% |
| BollingerBands ODDS (%) | 2 days ago 47% | 2 days ago 83% |
| Aroon ODDS (%) | 2 days ago 57% | 2 days ago 83% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| RSPA | 49.52 | 0.30 | +0.61% |
| Invesco S&P 500 Eq Wght Inc Adv ETF | |||
| FFLC | 47.36 | 0.19 | +0.40% |
| Fidelity Fundamental Large Cap Core ETF | |||
| DBL | 15.51 | -0.01 | -0.06% |
| Doubleline Opportunistic Credit Fund | |||
| DGP | 101.53 | -0.21 | -0.21% |
| DB Gold Double Long ETN | |||
| EWY | 66.16 | -0.32 | -0.48% |
| iShares MSCI South Korea ETF | |||
AMED and
Correlation & Price change
A.I.dvisor tells us that AMED and FMCQF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMED and FMCQF's prices will move in lockstep.
| Ticker / NAME | Correlation To AMED | 1D Price Change % | ||
|---|---|---|---|---|
| AMED | 100% | +2.78% | ||
| FMCQF - AMED | 24% Poorly correlated | N/A | ||
| OPCH - AMED | 23% Poorly correlated | +1.52% | ||
| USPH - AMED | 21% Poorly correlated | +0.53% | ||
| EHAB - AMED | 21% Poorly correlated | -0.56% | ||
| CYH - AMED | 20% Poorly correlated | -5.52% | ||
More | ||||
CYH and
Correlation & Price change
A.I.dvisor indicates that over the last year, CYH has been loosely correlated with UHS. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if CYH jumps, then UHS could also see price increases.
| Ticker / NAME | Correlation To CYH | 1D Price Change % | ||
|---|---|---|---|---|
| CYH | 100% | -5.52% | ||
| UHS - CYH | 54% Loosely correlated | -2.87% | ||
| THC - CYH | 45% Loosely correlated | -5.79% | ||
| HCA - CYH | 45% Loosely correlated | -2.17% | ||
| SGRY - CYH | 40% Loosely correlated | -0.17% | ||
| PNTG - CYH | 40% Loosely correlated | -1.66% | ||
More | ||||